Literature DB >> 7225250

Echocardiographic assessment of left ventricular filling characteristics after mitral valve replacement with the St Jude medical prosthesis.

M St John Sutton, R Roudaut, P Oldershaw, H Bricaud.   

Abstract

The major cause of late mortality and morbidity after prosthetic valve replacement is thromboembolism. The nidus for initiation of thrombus formation has been blood metal interfaces, and a new valve--the St Jude prosthesis--has therefore been developed without any metal components. We have assessed echocardiographically in 27 patients the effects of this valve on left ventricular filling characteristics when inserted in the mitral position and compared the findings with those in patients having mitral valve replacement with Starr-Edwards or Björk-Shiley prostheses and with those in patients undergoing repair of the native mitral valve. Echocardiograms were recorded and digitised. Measurements were made of the peak rate of increase of dimension (dD/dt) and duration of rapid filling. Values for the St Jude valve were 13.2 +/- 3.4 cm/s and 160 +/- 40 ms, respectively. The peak rate of dD/dt increase was significantly greater than with either the Björk-Shiley valve or the Starr-Edwards valve and was comparable with findings in mitral valve repair. The duration of the rapid filling phase was not significantly different from control values but was less than that of the Starr-Edwards valve. This study indicates that the new St Jude medical valve is less obstructive than either the Björk-Shiley or Starr-Edwards prostheses. This together with its low thrombogenicity suggests that further trials of this new valve should be undertaken.

Entities:  

Mesh:

Year:  1981        PMID: 7225250      PMCID: PMC482535          DOI: 10.1136/hrt.45.4.365

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  14 in total

1.  A new tilting disc valve prosthesis.

Authors:  V O Björk
Journal:  Scand J Thorac Cardiovasc Surg       Date:  1969

Review 2.  A critical analysis of the status of prosthetic valves and homografts.

Authors:  N S Braunwald; D E Detmer
Journal:  Prog Cardiovasc Dis       Date:  1968-09       Impact factor: 8.194

3.  Measurement of instantaneous left ventricular dimension and filling rate in man, using echocardiography.

Authors:  D G Gibson; D Brown
Journal:  Br Heart J       Date:  1973-11

4.  Role of echocardiography and phonocardiography in diagnosis of mitral paraprosthetic regurgitation with Starr-Edwards prostheses.

Authors:  H C Miller; D G Gibson; J D Stephens
Journal:  Br Heart J       Date:  1973-12

5.  Etiology of thrombus formation on prosthetic metal heart valves. The role of spontaneous in vivo interfacial potentials and their measurements.

Authors:  M E Lee; T Murakami; B Stanczewski; A Parmeggiani; S Srinivasan; P N Sawyer
Journal:  J Thorac Cardiovasc Surg       Date:  1972-05       Impact factor: 5.209

6.  Clinical and haemodynamic results of aortic valve replacement with the Björk-Shiley tilting disc valve prosthesis.

Authors:  V O Björk; A Holmgren; C Olin; C O Ovenfors
Journal:  Scand J Thorac Cardiovasc Surg       Date:  1971

7.  Echocardiographic assessment of left ventricular filling after mitral valve surgery.

Authors:  M G St John Sutton; T A Traill; A S Ghafour; D J Brown; D G Gibson
Journal:  Br Heart J       Date:  1977-12

8.  Ball valve prostheses: current appraisal of late results.

Authors:  L I Bonchek; A Starr
Journal:  Am J Cardiol       Date:  1975-06       Impact factor: 2.778

9.  Measurement of peak rates of left ventricular wall movement in man. Comparison of echocardiography with angiography.

Authors:  D G Gibson; D J Brown
Journal:  Br Heart J       Date:  1975-07

10.  Anticoagulants and the Björk-Shiley prosthesis. Experience of 390 patients.

Authors:  M G Sutton; G A Miller; P J Oldershaw; M Paneth
Journal:  Br Heart J       Date:  1978-05
View more
  1 in total

1.  Open mitral valvotomy: fourteen years' experience.

Authors:  P H Kay; P Belcher; K Dawkins; S C Lennox
Journal:  Br Heart J       Date:  1983-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.